Cargando…
A standard controlled clinical study on Virechana Karma and Lekhana Basti in the management of dyslipidemia (Medoroga)
BACKGROUND: Dyslipidemia, a major risk factor of coronary heart disease, is the leading single cause of death in the world. Currently available hypolipidemic agents have been associated with a large number of side effects. The radical Ayurveda Samshodhana Chikitsa as a treatment protocol can provide...
Autores principales: | Pooja, B.A, Bhatted, Santosh Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541465/ https://www.ncbi.nlm.nih.gov/pubmed/28827953 http://dx.doi.org/10.4103/ayu.AYU_14_15 |
Ejemplares similares
-
Efficacy of Virechana and Basti Karma with Shamana therapy in the management of essential hypertension: A comparative study
por: Shukla, Gyanendra, et al.
Publicado: (2013) -
Assessment of Lekhana Basti in the management of hyperlipidemia
por: Auti, Swapnil S., et al.
Publicado: (2013) -
A comparative clinical study of Nyagrodhadi Ghanavati and Virechana Karma in the management of Madhumeha
por: Kumari, Jyoti, et al.
Publicado: (2010) -
Role of Virechana Karma in cure and prevention of recurrence of Vicharchika (Eczema)
por: Kaur, Mandip, et al.
Publicado: (2012) -
Evaluation of anti-hyperlipidemic activity of Lekhana Basti in albino rats
por: Swapnil, S. Auti, et al.
Publicado: (2013)